Enhanced antibacterial and anti-biofilm activity of Tamarix aphylla ethanolic extract and its silver nanoparticles
International Journal of Health Sciences · 2025
DOI: 10.25259/ijhs_164_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Sciences, 2025. Verfasst von Ahmad N. Aljarbou. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objectives
Tamarix aphylla , a traditional medicinal plant, was investigated in this study for its antimicrobial and anti-biofilm activities. This study evaluated the efficacy of smoked ethanolic extract of Tamarix leaves (EETL) and its silver nanoparticle formulation (Ag-NPs-EETL) against both drug-sensitive and drug-resistant strains, including Staphylococcus aureus , methicillin-resistant S. aureus (MRSA), Escherichia coli , and colistin-resistant E. coli (CR- E. coli ).
Methods
Phytochemical profiling of EETL was performed using liquid chromatography electrospray ionization time-of-flight mass spectrometry. Ag-NPs-EETL was synthesized and characterized using ultraviolet-Vis and Fourier-transform infrared spectroscopy. The antibacterial activity was evaluated by agar well diffusion, minimum inhibitory concentration (MIC) determinations, and time-kill assays. Anti-biofilm efficacy was assessed using crystal violet staining. One-way analysis of variance was applied to determine the statistical significance.
Results
EETL showed inhibition zones of up to 25 mm and MICs of 200 µg/mL (MRSA) and 400 µg/mL (CR- E. coli ). Ag-NPs-EETL exhibited enhanced activity, with inhibition zones up to 36 mm and MICs as low as 100 µg/mL. The time-kill assay demonstrated >3-log reduction in CR- E. coli within 24 h for Ag-NPs-EETL. Anti-biofilm activity of Ag-NPs-EETL reached 92% inhibition for MRSA and 74% for CR- E. coli at 200 µg/mL, outperforming EETL (72% and 36%, respectively, P < 0.001).
Conclusion
Ag-NPs-EETL demonstrated significantly enhanced antimicrobial and anti-biofilm formation properties against multidrug-resistant pathogens. This formulation represents a promising alternative to combat multidrug-resistant infections. Future studies should focus on evaluating its in vivo therapeutic efficacy and safety for clinical applications.
Zitieren
APA
Aljarbou, A. N. (2025). Enhanced antibacterial and anti-biofilm activity of Tamarix aphylla ethanolic extract and its silver nanoparticles. International Journal of Health Sciences. https://doi.org/10.25259/ijhs_164_2025
Vancouver
Aljarbou AN. Enhanced antibacterial and anti-biofilm activity of Tamarix aphylla ethanolic extract and its silver nanoparticles. International Journal of Health Sciences. 2025. doi:10.25259/ijhs_164_2025
BibTeX
@article{Aljarbou2025,
author = {Aljarbou, Ahmad N.},
title = {Enhanced antibacterial and anti-biofilm activity of Tamarix aphylla ethanolic extract and its silver nanoparticles},
journal = {International Journal of Health Sciences},
year = {2025},
doi = {10.25259/ijhs_164_2025}
}
EUVIMED